Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 897 results for "sanofi"

Financial Results In Line With Expectations And Important Progress Of The Pipeline
TheStreet.com

Financial Results In Line With Expectations And Important Prog...

Reddit Email Print Reprint Growing lixisenatide (Lyxumia (r) ) royalty revenue In late July 2015, Sanofi submitted lixisenatide for regulatory approval in the US Successful completion of LixiLan-O, the first pivotal Phase III trial ... TheStreet.com, 1 day ago
[x]  
Pharmafile

Moves in pharma app market, but user longevity an issue

Sanofi's Go Meals is the most popular pharma app Pharma companies continue to invest in the mobile app market, but studies have found that pharma apps suffer the same longevity challenges as programmes in the wider market. Amsterdam-based ...
 Pharmafile1 day ago Discuss pharmaceutical market access strategies with MSD, Sanofi and GSK | European Pharmaceutical Pricing & Reimbursement  PRWeb2 days ago Horizon Pharma plc to Amend Preliminary Solicitation Statement to Include Proposed Nominees for Depomed's Board  Sys-Con Media1 week ago Pharmaceutical companies see a big market in "pharmerging" nations  Fortune2 weeks ago
Arab News

Sanofi launches new renal game for CKD patients

RIYADH: For Saudi men, remaining in the shadows of men in everyday life is passe. Backed by the government, they have now entered many areas of social and professional life, which they would have never dreamt of a few years ago.Saudi women have ...
 Arab News2 days ago
Seeking Alpha

Why Sanofi Deserves A Second Look

Aug. 24, 2015 6:08 PM ET | About: Sanofi (SNY), Includes: MNKD by: Summary Q2 results for Sanofi were encouraging despite the continued decline in Diabetes sales. The Q2 growth in sales was driven by the overall expansion of Sanofi's ...
 Seeking Alpha4 days ago

REL INFRA 366.05

REL.CAP. 339.75 RELIANCE 952.70 RELIGARE ENT 303.55 RENUKA SUGAR 8.58 RPOWER 42.00 RTNPOWER 7.09 SADBHAV ENGG 328.05 SANOFI 4154.80 SHIPP.CORPN 81.70 SHREE CEMENT 11155.85 SHRIRAM TRAN 861.10 SHRMCITYUN 1824.60 SIEMENS LTD. 1453.70 SINTEX IND. 102.85 SJVN ...
 Sify1 week ago REL INFRA 366.35  Sify1 week ago REL INFRA 371.45  Sify1 week ago REL INFRA 402.00  Sify2 weeks ago
Philippine Daily Inquirer

Diabetes drug shows 1st protection from heart complications

August 21st, 2015 12:05 PM This image provided by Sanofi and Regeneron Pharmaceuticals on Friday, July 24, 2015 shows packaging for the drug Praluent. The Food and Drug Administration on Friday approved this first-of-a-kind medication that lowers ...
 Philippine Daily Inquirer1 week ago Sanofi, Regeneron Pharmaceuticals Inc (NASDAQ:REGN)'s insider Acquired 10,639 Shares  Octafinance1 month ago REGENERON PHARMACEUTICALS : and Sanofi Announce CHMP Recommends European Approval of Praluent® alirocumab for the Treatment of Hypercholesterolemia  4 Traders1 month ago Regeneron Shares Rising After Sanofi Collaboration Revealed: Good News For Shareholders?  Yahoo! Finance1 month ago
[x]  
NBCNews.com

Video: SNY's new cancer fighting team

Sanofi partners with Evotec and Apeiron to develop immunotherapies
 NBCNews.com2 weeks ago Sanofi, Evotec, Apeiron make cancer-therapy deal  News.am2 weeks ago Evotec, Apeiron Biologics And Sanofi Jointly Develop Novel Small Molecule-Based Cancer Immunotherapies  TheStreet.com2 weeks ago Sanofi Partners With Apeiron And Evotec To Develop Drug For Blood Cancers And Solid Tumors  Tech Times2 weeks ago
[x]  
TheStreet.com

Sanofi - Résultats T2 2015 Interview du Directeur Général Olivier Brandicourt

/PRNewswire/ -- Sanofi, un leader mondial et diversifié de la santé, publie ses résultats pour le premier semestre 2015. Le Directeur Général Olivier Brandicourt commente les résultats. Visionner l ' interview vidéo et lire la ...
 PR Newswire1 month ago Sanofi's new CEO delivers strong 2nd-qtr results, as profits leap  Pharma Letter1 month ago Sanofi H1 2015 Results - Interview with CEO Olivier Brandicourt  Sys-Con Media1 month ago Sanofi (SNY) H1 2015 Results - Interview With CEO Olivier Brandicourt 7/31/2015  ClinicSpace4 weeks ago
[x]  
Money Control

Sanofi India rallies 3% after decent Q2 earnings

The pharma company booked a net profit of Rs. 64.20 crore for the second quarter ended June 2015, when compared with Rs. 57.50 crore in the corresponding period a year ago.
 India Infoline1 month ago Sanofi India gains after reporting decent Q2 results  Business Standard1 month ago Sanofi India standalone net profit rises 11.65% in the June 2015 quarter  Business Standard1 month ago Sanofi India Q2 net up 12 pc at Rs 64.2 cr  Business Standard1 month ago
[x]  
RSC

Grabbing slices of the immuno-oncology pie

Another round of immuno-oncology deals underlines the popularity of harnessing the immune system to attack cancer. Sanofi is partnering Regeneron; Merck & Co is extending its relationship with Ablynx and buying cCAM Biotherapeutics; and Five Prime ...
 RSC3 weeks ago Sanofi and Regeneron enter into new immuno-oncology collaboration  Individual.com3 weeks ago Sanofi joins Regeneron in $2.2 billion pact for cancer therapies  Boston Globe1 month ago Sanofi & Regeneron Enter Immuno-Oncology Collaboration  Zacks.com1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sanofi
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less